Kodi-M Co Ltd (224060) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kodi-M Co Ltd (224060) has a cash flow conversion efficiency ratio of -0.107x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.21 Billion ≈ $-1.49 Million USD) by net assets (₩20.64 Billion ≈ $13.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kodi-M Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Kodi-M Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Kodi-M Co Ltd (224060) total liabilities for a breakdown of total debt and financial obligations.
Kodi-M Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kodi-M Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Newtree S.A
BR:NEWT
|
0.060x |
|
Games Operators SA
WAR:GOP
|
0.091x |
|
Almadex Minerals Ltd
V:DEX
|
-0.007x |
|
Tek Seng Holdings Bhd
KLSE:7200
|
0.087x |
|
Masterkool International Public Company Limited
BK:KOOL
|
-0.034x |
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
-0.136x |
|
EV Advanced Material Co.Ltd
KQ:131400
|
-0.068x |
|
Harte Hanks Inc
NASDAQ:HHS
|
0.189x |
Annual Cash Flow Conversion Efficiency for Kodi-M Co Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Kodi-M Co Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 224060 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩45.19 Billion ≈ $30.63 Million |
₩-5.32 Billion ≈ $-3.60 Million |
-0.118x | +42.92% |
| 2023-12-31 | ₩32.17 Billion ≈ $21.80 Million |
₩-6.63 Billion ≈ $-4.49 Million |
-0.206x | +43.10% |
| 2022-12-31 | ₩46.97 Billion ≈ $31.83 Million |
₩-17.02 Billion ≈ $-11.53 Million |
-0.362x | -86.76% |
| 2021-12-31 | ₩55.69 Billion ≈ $37.74 Million |
₩-10.80 Billion ≈ $-7.32 Million |
-0.194x | +31.34% |
| 2020-12-31 | ₩79.93 Billion ≈ $54.17 Million |
₩-22.59 Billion ≈ $-15.31 Million |
-0.283x | +8.88% |
| 2019-12-31 | ₩65.51 Billion ≈ $44.39 Million |
₩-20.31 Billion ≈ $-13.77 Million |
-0.310x | -1368.33% |
| 2018-12-31 | ₩56.29 Billion ≈ $38.15 Million |
₩1.38 Billion ≈ $932.73K |
0.024x | +288.85% |
| 2017-12-31 | ₩55.27 Billion ≈ $37.45 Million |
₩-715.52 Million ≈ $-484.90K |
-0.013x | +97.41% |
| 2016-12-31 | ₩15.85 Billion ≈ $10.74 Million |
₩-7.91 Billion ≈ $-5.36 Million |
-0.499x | -377.13% |
| 2015-12-31 | ₩12.28 Billion ≈ $8.32 Million |
₩2.21 Billion ≈ $1.50 Million |
0.180x | -- |
About Kodi-M Co Ltd
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and chang… Read more